23 January 2017
News and Views
Links and Services
Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment, reports the latest issue of the Alimentary Pharmacology & Therapeutics.
Metformin use has been associated with a decreased incidence and mortality of various cancers.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors